TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients	Antibody-mediated Rejection	Active, not recruiting	Phase 3	2026-08-10		NCT04561986

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Complexo Hospitalario Universitario de A Coruña	6
Hospital del Mar	25
Hospital Universitario Doctor Peset	7
Karolinska University Hospital	181
The Swedish Research Council	57
Uppsala University Hospital	80
Vastra Gotaland Region	163

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Complejo Hospitalario Universitario A Coruña	A Coruña	Spain	7
Hospital del Mar	Barcelona	Spain	46
Hospital Universitario Dr. Peset	Valencia	Spain	1
Karolinksa University Hospital	Stockholm	Sweden	1
Transplant Center, Sahlgrenska University Hospital	Gothenburg	Sweden	1
Uppsala University Hospital	Uppsala	Sweden	3